Pharmaceutical - Immunologicals, Oncology


Current filters:


Popular Filters

Merck Serono on track with pharma strategy

Merck Serono on track with pharma strategy


Germany’s Merck KGaA says that its biopharmaceutical division - Merck Serono - is well on track with…

ataciceptBiosimilarsFinancialGermanyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302

Ligand in licensing deal with TG Thera for IRAK-4 inhibitor program

Ligand in licensing deal with TG Thera for IRAK-4 inhibitor program


US drugmaker Ligand Pharmaceuticals has signed an exclusive global license accord with TG Therapeutics…

ImmunologicalsLicensingLigand PharmaceuticalsOncologyPharmaceuticalTG Therapeutics

Scancell granted orphan drug designation for melanoma drug

Scancell granted orphan drug designation for melanoma drug


UK-based immunotherapy company Scancell has been granted orphan drug designation for its SCIB1 ImmunoBody…


AbbVie to spend $320 million to establish Singapore manufacturing presence

AbbVie to spend $320 million to establish Singapore manufacturing presence


US drugmaker AbbVie says it plans to invest $320 million to establish operations in Singapore for small…


Medigene’s buy of Trianta is “lucrative move” say analysts


Medigene’s 4 million euro ($5.5 million) purchase of fellow German company Trianta Immunotherapies…

FinancialImmunologicalsMedigeneMergers & AcquisitionsOncologyPharmaceuticalTrianta ImmunotherapiesUSA

Swedish researcher report on unexpected use of former cancer drug


Researchers at Sweden's Lund University have unexpectedly discovered that an old cancer drug - zebularine…


Merck Serono sets up new platform for cancer therapies innovation


Merck Serono, the biopharmaceutical division of Germany's Merck KGaA (MRK: DE) says it has created a…

BiotechnologyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Additional indications in Japan for Roche's Avastin and Astellas' Prograf


Swiss drug major Roche (ROG: SIX) says that the Japanese Ministry of Health, Labor and Welfare (MHLW)…

Asia-PacificAstellas PharmaAvastinBiotechnologyImmunologicalsOncologyPharmaceuticalPrografRegulationRoche

Hikma in-licenses inhaled insulin for MENA; Advaxis and FusionVax Asia deal


Jordan-based Hikma Pharmaceuticals (LSE: HIK) has signed a licensing and distribution agreement with…

AdvaxisADXS-HPVAsia-PacificDance 01Dance BiopharmDiabetesFusionVaxHikma PharmaceuticalsImmunologicalsLicensingOncologyPharmaceuticalRest of the World

Bayer expands collaboration with DKFZ into immunotherapy


German drug major Bayer (BAYN: DE) said revealed this morning that it will extend if already successful…


European therapeutic MAbs market to reach over $42 billion in 2018, says F&S


Efficient resource to therapy of complex disorders with lesser side effects has accelerated growth of…

BiotechnologyImmunologicalsInflammatory diseasesMarkets & MarketingOncologyPharmaceuticalResearch

GlaxoSmithKline links with Japan's Chiome on MAbs


UK pharma giant GlaxoSmithKline group (LSE: GSK) and Tokyo, Japan-based biotech-venture company Chiome…

BiotechnologyChiome BioscienceGlaxoSmithKlineImmunologicalsLicensingOncologyPharmaceuticalResearch

Ablynx extends Nanobody deal with Boehringer


Belgian drug developer Ablynx (Euronext Brussels: ABLX) yesterday announced a two-year extension of the…

AblynxBiotechnologyBoehringer IngelheimImmunologicalsLicensingOncologyPharmaceuticalRespiratory and Pulmonary

Back to top